Christopher Morabito

465 total citations
12 papers, 322 citations indexed

About

Christopher Morabito is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Christopher Morabito has authored 12 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Genetics. Recurrent topics in Christopher Morabito's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Congenital heart defects research (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Christopher Morabito is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Congenital heart defects research (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Christopher Morabito collaborates with scholars based in United States, Netherlands and Canada. Christopher Morabito's co-authors include James Bristow, Javier Kattan, Robert W. Dettman, J.M. Collier, Bagirath Gangadharan, Steven M. Donn, Fernando Moya, James J. Cummings, Carl Bose and Robert Segal and has published in prestigious journals such as PEDIATRICS, Journal of Allergy and Clinical Immunology and Developmental Biology.

In The Last Decade

Christopher Morabito

10 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Morabito United States	8	229	113	99	84	42	12	322
James Chappell United States	8	180 0.8×	43 0.4×	138 1.4×	58 0.7×	26 0.6×	9	352
Menglan Xiang United States	6	130 0.6×	33 0.3×	38 0.4×	17 0.2×	51 1.2×	9	244
Scott C. Boyle United States	8	255 1.1×	48 0.4×	78 0.8×	24 0.3×	19 0.5×	8	303
Scott D. Collum United States	11	114 0.5×	36 0.3×	225 2.3×	40 0.5×	19 0.5×	23	354
Tomokazu Hoshi Japan	5	78 0.3×	124 1.1×	27 0.3×	21 0.3×	39 0.9×	8	348
Bibha Choudhary United States	3	312 1.4×	95 0.8×	87 0.9×	55 0.7×	81 1.9×	3	342
Meenakshi Maitra United States	4	239 1.0×	58 0.5×	151 1.5×	45 0.5×	131 3.1×	5	361
Jolanta Kole United States	7	293 1.3×	69 0.6×	145 1.5×	14 0.2×	18 0.4×	8	439
Corey M. Williams United States	6	184 0.8×	37 0.3×	26 0.3×	27 0.3×	24 0.6×	11	310
Lindsey J. Anstine United States	10	152 0.7×	32 0.3×	67 0.7×	101 1.2×	27 0.6×	11	276

Countries citing papers authored by Christopher Morabito

Since Specialization

Citations

This map shows the geographic impact of Christopher Morabito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Morabito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Morabito more than expected).

Fields of papers citing papers by Christopher Morabito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Morabito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Morabito. The network helps show where Christopher Morabito may publish in the future.

Co-authorship network of co-authors of Christopher Morabito

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Morabito. A scholar is included among the top collaborators of Christopher Morabito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Morabito. Christopher Morabito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Lumry, William R., et al.. (2025). Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults. Annals of Allergy Asthma & Immunology. 135(1). 103–111.e2. 2 indexed citations

Jacobs, Joshua, Adil Adatia, Timothy Craig, et al.. (2025). Treatment with Navenibart (STAR-0215) Reduces Attack Severity and Use of Rescue Medication in Patients with Hereditary Angioedema (HAE): Interim Results from the ALPHA-STAR Trial. Journal of Allergy and Clinical Immunology. 155(2). AB196–AB196.

Morabito, Christopher, Christian V. Stevens, Pradeep Bista, et al.. (2023). Initial Results from a Phase 1 Single Ascending Dose Clinical Trial of STAR-0215, an Investigational Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for Hereditary Angioedema (HAE), in Healthy Subjects Followed for at Least 3 Months. Journal of Allergy and Clinical Immunology. 151(2). AB136–AB136. 3 indexed citations

Morabito, Christopher & Bagirath Gangadharan. (2020). Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID‐19. Clinical and Translational Science. 13(5). 835–837. 12 indexed citations

Knox, Clayton D., Pieter‐Jan de Kam, Karim Azer, et al.. (2016). Discovery and Clinical Evaluation of MK‐8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release. Journal of the American Heart Association. 5(9). 11 indexed citations

Lip, Gregory Y.H., Anselm K. Gitt, Jean‐Yves Le Heuzey, et al.. (2013). Overtreatment and Undertreatment With Anticoagulation in Relation to Cardioversion of Atrial Fibrillation (the RHYTHM-AF Study). The American Journal of Cardiology. 113(3). 480–484. 16 indexed citations

Lynch, Joseph J., Christopher P. Regan, Gregory N. Beatch, Gilbert W. Gleim, & Christopher Morabito. (2012). Comparison of the Intrinsic Vasorelaxant and Inotropic Effects of the Antiarrhythmic Agents Vernakalant and Flecainide in Human Isolated Vascular and Cardiac Tissues. Journal of Cardiovascular Pharmacology. 61(3). 226–232. 9 indexed citations

Laughon, Matthew M., Carl Bose, Fernando Moya, et al.. (2008). A Pilot Randomized, Controlled Trial of Later Treatment With a Peptide-Containing, Synthetic Surfactant for the Prevention of Bronchopulmonary Dysplasia. PEDIATRICS. 123(1). 89–96. 37 indexed citations

Dettman, Robert W., et al.. (2003). Inhibition of α4-integrin stimulates epicardial–mesenchymal transformation and alters migration and cell fate of epicardially derived mesenchyme. Developmental Biology. 257(2). 315–328. 36 indexed citations

10.

Morabito, Christopher, Javier Kattan, & James Bristow. (2002). Mechanisms of embryonic coronary artery development. Current Opinion in Cardiology. 17(3). 235–241. 40 indexed citations

11.

Morabito, Christopher, Robert W. Dettman, Javier Kattan, J.M. Collier, & James Bristow. (2001). Positive and Negative Regulation of Epicardial–Mesenchymal Transformation during Avian Heart Development. Developmental Biology. 234(1). 204–215. 156 indexed citations

12.

Kattan, Javier, Robert W. Dettman, Christopher Morabito, & James Bristow. (1999). Coronary Vascular Development and Remodeling in the Developing Quail Heart. Pediatric Research. 45(4, Part 2 of 2). 25A–25A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact